Latest Articles

Publication Date
All News Scientific
Merck’s endometrial cancer drug meets trial goals By Investing.com - Investing.com Canada

Merck’s endometrial cancer drug meets trial goals By Investing.com Investing.com Canada

Published: May 18, 2026, 11:01 a.m.
Read Full Article
Merck's endometrial cancer drug meets late-stage trial goals - Reuters

Merck's endometrial cancer drug meets late-stage trial goals Reuters

Published: May 18, 2026, 10:51 a.m.
Read Full Article
Merck's endometrial cancer drug meets late-stage trial goals - Yahoo Finance

Merck's endometrial cancer drug meets late-stage trial goals Yahoo Finance

Published: May 18, 2026, 10:51 a.m.
Read Full Article
Merck endometrial cancer drug meets survival goals in phase 3 trial - StreetInsider

Merck endometrial cancer drug meets survival goals in phase 3 trial StreetInsider

Published: May 18, 2026, 10:47 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - MSN

GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug MSN

Published: May 17, 2026, 7:18 p.m.
Read Full Article
The Four Types of Therapy for Second-Line Endometrial Cancer - CancerNetwork

The Four Types of Therapy for Second-Line Endometrial Cancer CancerNetwork

Published: May 16, 2026, 2:04 p.m.
Read Full Article
Navigating the Evolving Landscape of Second-Line Endometrial Cancer Care - CancerNetwork

Navigating the Evolving Landscape of Second-Line Endometrial Cancer Care CancerNetwork

Published: May 15, 2026, 2:05 p.m.
Read Full Article
Bidirectional Mendelian Randomization and Single‑Cell RNA Sequencing Reveal an NK Cell-Mediated Causal Link Between Endometriosis and Endometrial Cancer.

Endometriosis is a chronic estrogen-dependent inflammatory disease that shares epidemiological and pathological features with endometrial cancer. However, the cellular and genetic mechanisms underlying this association remain unclear.

Published: May 15, 2026, midnight
Read Full Article
Mendelian randomization endometrial cancer endometriosis natural killer cells single-cell RNA sequencing
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!